Access
To read this story in full you will need to login or make a payment (see right).
Commentary
Nature 455, 730-731 (9 October 2008) | doi:10.1038/455730a; Published online 8 October 2008
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
- More Challenges
- Powered by:
nature jobs
Chair, Department of Informatic Medicine and Personalized Health
- University of Missouri-Kansas City
- Kansas City, Missouri, USA
Fellowships
- Brighams and Women's Hospital
- Boston, MA
A network solution
Adriano Henney1 & Giulio Superti-Furga2
- Adriano Henney is a director of Global Discovery Enabling Capabilities and Sciences at AstraZeneca, Alderley Park, UK.
Email: adriano.henney@btinternet.com - Giulio Superti-Furga directs the Center for Molecular Medicine of the Austrian Academy of Sciences in Vienna, Austria.
Email: gsuperti@cemm.oeaw.ac.at
Abstract
With the right plan, systems biology can empower drug discovery, say Adriano Henney and Giulio Superti-Furga. Field leaders have contributed and now the authors want to hear from you.
Systems biology focuses on interactions within and between the mechanisms that combine to give rise to the function and behaviour of a biological system. To some it is the logical and inevitable next-level understanding that will propel drug discovery from empiricism to mechanism-based rational design.
To read this story in full you will need to login or make a payment (see right).
